Sat Sep 21 11:24:46 UTC 2024: ## Edgestream Partners Invests in CVS Health, Institutional Investors Show Mixed Interest

**New York, NY – September 21, 2024** – Edgestream Partners L.P. has acquired a new stake in CVS Health Co. (NYSE:CVS) during the second quarter, according to the firm’s recent SEC filing. The investment firm purchased 19,297 shares of the pharmacy operator, valued at approximately $1,140,000.

While Edgestream’s investment signals confidence in CVS Health, other institutional investors have shown mixed interest in the company. Steph & Co. increased its stake by 192.0% in the first quarter, while Douglas Lane & Associates LLC raised its stake by 1.6%. However, some investors, including OLD Point Trust & Financial Services N A, acquired new positions in CVS Health, while others, like BOCHK Asset Management Ltd, purchased new shares in the fourth quarter.

Overall, institutional investors currently own 80.66% of CVS Health’s stock.

CVS Health opened at $57.51 on Friday, with a 52-week low of $52.77 and a 52-week high of $83.25. The company announced a quarterly dividend of $0.665 per share, payable on November 1st.

Analysts have issued mixed ratings on CVS Health. While some, like Robert W. Baird and Cantor Fitzgerald, have maintained a “neutral” rating, others have issued “hold” ratings and even upgraded the stock to a “hold” rating. Currently, the stock has a consensus rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Corporation provides health solutions in the United States, operating through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.

Read More